Federal Science Funding Barely Keeps Pace With Inflation

Researchers fearing that the agreement between Congress and President Clinton to balance the federal budget by 2002 would decimate science funding can rest a little easier. Each of the eight major federal departments funding research will at least keep pace with or slightly exceed the 2.6 percent inflation rate in FY1998-with the exception of the Department of Agriculture, which will receive 2 percent less research funding in real dollars. As expected, Congress met or exceeded the president's b

Written byPaul Smaglik
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Researchers fearing that the agreement between Congress and President Clinton to balance the federal budget by 2002 would decimate science funding can rest a little easier. Each of the eight major federal departments funding research will at least keep pace with or slightly exceed the 2.6 percent inflation rate in FY1998-with the exception of the Department of Agriculture, which will receive 2 percent less research funding in real dollars. As expected, Congress met or exceeded the president's budgetary requests for R&D, with a few exceptions.

However, the FY1998 budget fails to significantly reverse the long-term trend of slow erosion in science funding in the 1990s due to inflation. Total federal research has grown at an average of less than 1 percent a year since 1990, according to a National Science Foundation analysis, "Survey of Federal Funds for Research and Development" (NSF Publication 97-302). The report illustrates that 1997's 1.3 percent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies